Stabilized GHRH analog without the drug affinity complex (DAC). Drives a clean GH pulse without the days-long elevation.
Reference facts
- Also known as
- Mod GRF 1-29, Modified GRF
- Category
- Growth Hormone & Ghrelin
- Mechanism of action
- Stabilized GHRH analog without the drug affinity complex (DAC). Drives a clean GH pulse without the days-long elevation.
- Targets
- GHRHR
- Indications under research or approved
- Off-label research (adult GH support)
- Regulatory status (reference entry)
- Not FDA-approved
- Half-life
- ~30 minutes
- Sequence
- YADAIFTNSYRKVLGQLSARKLLQDIMSR
- Sequence notes
- Tetrasubstituted Sermorelin: D-Ala²,Gln⁸,Ala¹⁵,Leu²⁷. The four substitutions resist DPP-4 cleavage and asparagine rearrangement.
- Molecular weight (Da)
- 3367
- Originator / sponsor
- Originally ConjuChem (research)
- First reported
- 2005
Primary References
Explore research articles about CJC-1295 (no DAC)
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.